Misrepresentation of statin safety evidence

被引：10

作者：

Armitage, Jane ^{[1
]}

Baigent, Colin ^{[1
]}

Collins, Rory ^{[1
]}

机构：

[1] Univ Oxford, Clin Trial Serv Unit, Oxford OX3 7LF, England

来源：

LANCET | 2014年 / 384卷 / 9950期

基金：

英国医学研究理事会;

关键词：

D O I：

10.1016/S0140-6736(14)61765-7

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1263 / 1264

页数：2

共 5 条

[1]

[Anonymous], 2014, LIP MOD CARD RISK AS

[2] Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk individuals with subclinical atherosclerosis - The METEOR trial [J].

Crouse, John R., III ;

Raichlen, Joel S. ;

Riley, Ward A. ;

Evans, Gregory W. ;

Palmer, Mike K. ;

O'Leary, Daniel H. ;

Grobbee, Diederick E. ;

Bots, Michiel L. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 297 (12) :1344-1353

[3]

Haslam D, NICE DRAFT GUIDANCE

[4] PREVENTION OF CORONARY HEART-DISEASE WITH PRAVASTATIN IN MEN WITH HYPERCHOLESTEROLEMIA [J].

SHEPHERD, J ;

COBBE, SM ;

FORD, I ;

ISLES, CG ;

LORIMER, AR ;

MACFARLANE, PW ;

MCKILLOP, JH ;

PACKARD, CJ .

NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (20) :1301-1307

[5]

Thompson R, LATEST NICE DRAFT GU

← 1 →